BQ Prime spoke with Mr. Himanshu Baid, MD, Polymed. He has highlighted that #polymed will be investing in new technologies and innovations for better patient care. On guidance for FY24 #polymed targets EBITDA Margin of around 25%. #polymedicure #polymedicureshare #MakeInIndia

March 31, 20250 CommentsPoly Medicure Ltd.

BQ Prime spoke with Mr. Himanshu Baid, MD, Polymed. He has highlighted that #polymed will be investing in new technologies and innovations for better patient care.
On guidance for FY24 #polymed targets EBITDA Margin of around 25%.

Recent Posts